D-0112-2025 Class II Terminated

Recalled by Lannett Company Inc. — Seymour, IN

FDA drug recall D-0112-2025 was initiated by Lannett Company Inc. on Oct 25, 2024 and is designated Class II. Reason for recall: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity. The recall status is terminated (terminated Jun 27, 2025). Affected quantity: 1608 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 11, 2024
Initiation Date
Oct 25, 2024
Termination Date
Jun 27, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1608 bottles

Product description

Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37

Reason for recall

Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.

Distribution pattern

Nationwide in the USA

Code information

Lot: 23274856A, Exp 04/30/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0112-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0112-2025. Report a data issue: hello@regdatalab.com.